BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21293281)

  • 1. Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study.
    Roteli-Martins CM; de Carvalho NS; Naud P; Teixeira J; Borba P; Derchain S; Tyring S; Gall S; Diaz A; Blatter M; Shier RM; Romanowski B; Quint WG; Issam J; Galindo C; Schuind A; Dubin G
    Int J Gynecol Pathol; 2011 Mar; 30(2):173-84. PubMed ID: 21293281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women.
    Panotopoulou E; Tserkezoglou A; Kouvousi M; Tsiaousi I; Chatzieleftheriou G; Daskalopoulou D; Magiakos G
    J Med Virol; 2007 Dec; 79(12):1898-905. PubMed ID: 17935171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of cervical human papillomavirus infection and types among women immigrated to Sicily, Italy.
    Giovannelli L; Vassallo R; Matranga D; Affronti M; Caleca MP; Bellavia C; Perino A; Ammatuna P
    Acta Obstet Gynecol Scand; 2009; 88(6):737-42. PubMed ID: 19412805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy.
    Broccolo F; Chiari S; Piana A; Castiglia P; Dell'Anna T; Garcia-Parra R; Maneo A; Villa A; Leone EB; Perego P; Maida A; Mangioni C; Cocuzza CE
    J Med Virol; 2009 Feb; 81(2):278-87. PubMed ID: 19107971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control.
    Giuliano AR; Papenfuss M; Abrahamsen M; Denman C; de Zapien JG; Henze JL; Ortega L; Brown de Galaz EM; Stephan J; Feng J; Baldwin S; Garcia F; Hatch K
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1129-36. PubMed ID: 11700260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
    Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
    J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.
    Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Brown DR; Elbasha EH; Paavonen J; Haupt RM;
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1585-94. PubMed ID: 20530494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
    Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
    Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women.
    Nielsen A; Kjaer SK; Munk C; Iftner T
    Sex Transm Dis; 2008 Mar; 35(3):276-82. PubMed ID: 18091564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical infection with human papillomavirus (HPV) 6 or 11 in high-risk women in Burkina Faso.
    Low A; Didelot-Rousseau MN; Nagot N; Ouedraougo A; Clayton T; Konate I; Van de Perre P; Segondy M; Mayaud P
    Sex Transm Infect; 2010 Oct; 86(5):342-4. PubMed ID: 20410079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
    Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
    Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study.
    Iftner T; Eberle S; Iftner A; Holz B; Banik N; Quint W; Straube AN
    J Med Virol; 2010 Nov; 82(11):1928-39. PubMed ID: 20872721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil.
    Paesi S; Serafini EP; Barea F; Madi SR; Echeverrigaray S
    J Med Virol; 2009 Jul; 81(7):1270-5. PubMed ID: 19475616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
    Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
    J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of different HPV types in Turkish women with a normal Pap smear.
    Demir ET; Ceyhan M; Simsek M; Gunduz T; Arlier S; Aytac R; Aycan AE; Gurbuz V
    J Med Virol; 2012 Aug; 84(8):1242-7. PubMed ID: 22711352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in factors associated with oncogenic and nononcogenic human papillomavirus infection at the United States-Mexico border.
    Giuliano AR; Papenfuss M; Abrahamsen M; Inserra P
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):930-4. PubMed ID: 12223441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.